KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

NovoCure (NVCR) Asset Utilization Ratio (2016 - 2025)

NovoCure's Asset Utilization Ratio history spans 11 years, with the latest figure at 0.61 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 23.15% year-over-year to 0.61; the TTM value through Dec 2025 reached 0.61, up 23.15%, while the annual FY2025 figure was 0.64, 26.38% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.61 at NovoCure, up from 0.49 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.61 in Q4 2025 and bottomed at 0.44 in Q2 2023.
  • The 5-year median for Asset Utilization Ratio is 0.47 (2021), against an average of 0.48.
  • The largest annual shift saw Asset Utilization Ratio plummeted 47.45% in 2021 before it increased 23.15% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.47 in 2021, then dropped by 3.98% to 0.45 in 2022, then fell by 2.27% to 0.44 in 2023, then increased by 10.61% to 0.49 in 2024, then grew by 23.15% to 0.61 in 2025.
  • Per Business Quant, the three most recent readings for NVCR's Asset Utilization Ratio are 0.61 (Q4 2025), 0.49 (Q3 2025), and 0.51 (Q2 2025).